Trials / Completed
CompletedNCT02152696
Optimal Treatment for Women With a Persisting Pregnancy of Unknown Location
Optimal Treatment for Women With a Persisting Pregnancy of Unknown Location - a Randomized Clinical Trial of Women at Risk for an Ectopic Pregnancy: Active Treatment Versus No Treatment
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 255 (actual)
- Sponsor
- Yale University · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a randomized controlled trial to compare three currently available management strategies for women with a persisting pregnancy of unknown location (PPUL), which makes them at-risk for ectopic pregnancy. We will recruit hemodynamically stable women with a confirmed PPUL to be randomized to one of three strategies: 1) Uterine evacuation followed by methotrexate (MTX) for some (those that have evidence of a non visualized ectopic pregnancy) 2) Empiric treatment with MTX for all 3) Expectant management. Randomization will be 1:1:1 into these three arms. After randomization, they will be followed and treated clinically as is indicated by the progression of their condition. Primary outcome measures: uneventful decline of hCG to 5 IU/mL.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Methotrexate | Two Dose Protocol: The patient will receive the first dose of MTX 50mg/m2 on treatment day 0. She will receive a second dose of MTX 50mg/m2 on treatment day 4 and a serum hCG level will be drawn. Subsequent doses of MTX will be administered based on hCG levels. |
| PROCEDURE | Uterine Evacuation | Uterine evacuation or dilation and curettage. At the clinician's discretion, this can be performed using local anesthesia, sedation or general anesthesia and can use a manual or electrical evacuation. |
| OTHER | Expectant Management | Pregnancy will be expectantly managed using serum hcg monitoring |
Timeline
- Start date
- 2014-07-25
- Primary completion
- 2019-08-01
- Completion
- 2019-08-19
- First posted
- 2014-06-02
- Last updated
- 2020-12-08
- Results posted
- 2020-10-26
Locations
17 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02152696. Inclusion in this directory is not an endorsement.